ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,236.68
0.43%
US Tech 100
17,720.40
0.45%
다우존스 지수
39,549.15
0.41%
Bitcoin
62,957.60
-0.14%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Lipocine Inc (LPCN)

  7. Lipocine Inc (LPCN) 뉴스

LPCN

Lipocine (LPCN)

Lipocine Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:LPCN
일자시간출처헤드라인심볼기업
2024/05/0921:00PR Newswire (US)Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024NASDAQ:LPCNLipocine Inc
2024/05/0919:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPCNLipocine Inc
2024/05/0919:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/05/0821:00PR Newswire (US)Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024NASDAQ:LPCNLipocine Inc
2024/05/0819:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/05/0121:00PR Newswire (US)Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154NASDAQ:LPCNLipocine Inc
2024/04/1120:00PR Newswire (US)Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityNASDAQ:LPCNLipocine Inc
2024/03/2821:00PR Newswire (US)Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with CirrhosisNASDAQ:LPCNLipocine Inc
2024/03/2521:00PR Newswire (US)Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
2024/03/0807:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/03/0722:00PR Newswire (US)Lipocine Announces Financial Results for the Full Year Ended December 31, 2023NASDAQ:LPCNLipocine Inc
2024/03/0720:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/03/0720:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LPCNLipocine Inc
2024/03/0622:00PR Newswire (US)Lipocine to Present at 36th Annual Roth ConferenceNASDAQ:LPCNLipocine Inc
2024/03/0620:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/02/1306:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/02/0622:00PR Newswire (US)Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
2024/02/0222:00PR Newswire (US)Lipocine Announces Continued Commercialization of TLANDO® through Verity PharmaceuticalsNASDAQ:LPCNLipocine Inc
2024/01/1822:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2024/01/1822:00PR Newswire (US)Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and CanadaNASDAQ:LPCNLipocine Inc
2023/12/2000:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2023/12/1922:00PR Newswire (US)Lipocine to Present at Biotech Showcase 2024NASDAQ:LPCNLipocine Inc
2023/11/2306:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LPCNLipocine Inc
2023/11/1404:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2023/11/1404:45PR Newswire (US)Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023NASDAQ:LPCNLipocine Inc
2023/11/0903:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPCNLipocine Inc
2023/11/0823:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2023/11/0822:00PR Newswire (US)Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023NASDAQ:LPCNLipocine Inc
2023/11/0122:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
2023/11/0121:00PR Newswire (US)Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023NASDAQ:LPCNLipocine Inc
 검색 관련기사 보기:NASDAQ:LPCN

최근 히스토리

CCOM
SILVER
SILVER
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
AMEX
XLF
Financial Select Sector
NYSE
VZ
Verizon Communications
FX
USDJPY
US Dollar vs Yen
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유